Abstract:PEGylation increases the circulation time of the nanocarrier, but also triggers accelerated blood clearance (ABC) phenomenon. It is well-known that the ABC phenomenon results in shortened blood circulation and aberrant increase in liver and spleen accumulation, which greatly limits the application of PEGylated nano-preparations. For many years, researchers have been working hard to find ways to reduce or eliminate the ABC phenomenon. Previous studies have focused on PEG molecular weight and PEG alternative materials, but there has never been any research on the effect of different PEG chain types on the ABC phenomenon. Therefore, 40 kDa molecular weight of linear PEG lipid derivatives (DSPE-mPEG40k) and branched PEG lipid derivatives (DSPE-mPEG2,40k) were selected to modify nanoemulsions to explore the influence of distinct PEG chain types on avoiding the ABC phenomenon for the first time. We pioneer the use of linear and branched PEG lipid derivatives (DSPE-mPEG40k and DSPE-mPEG2,40k) to modify nanoemulsions (PE40k and PE2,40k). Upon characterization, PE40k and PE2,40k showed good physicochemical properties in the aspect of size, polydispersity index (PDI value), and zeta potential. Surprisingly, the pharmacokinetics study indicated that repeated injection of PE40k and PE2,40k did not trigger the ABC phenomenon. More importantly, PE2,40k possessed a long circulation time and did not cause ABC phenomenon after repeated injection. This may be attributed to the fact that PE2,40k induced noticeably lower anti-PEG IgM levels compared to linear PEG-modified nanocarriers and did not activate the complement system. Therefore, we speculate that DSPE-mPEG2,40k-modified nanocarriers possess promising prospects in avoiding the ABC phenomenon, which may improve the possibility of wide application of nanoformulations.

Precipitation-Mediated PEGylation of Plant-Derived Nanovesicles

Plant-Derived Vesicle-Like Nanoparticles: Clinical Application Exploration and Challenges

Advances in PEGylated targeted nano-preparation

Ph Responsive Pegylation Through Metal Affinity for Gene Delivery Mediated by Histidine-Grafted Polyethylenimine

Disulfide-bridged Cleavable PEGylation in Polymeric Nanomedicine for Controlled Therapeutic Delivery

Plant Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future

Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake

Controlled PEGylation Crowdedness for Polymeric Micelles to Pursue Ligand-Specified Privileges As Nucleic Acid Delivery Vehicles

Linear and multivalent PEGylation of the tobacco mosaic virus and the effects on its biological properties

Achievements and Bottlenecks of PEGylation in Nano-delivery Systems

Poly(ethyl Ethylene Phosphate): Overcoming the "polyethylene Glycol Dilemma" for Cancer Immunotherapy and Mrna Vaccination.

Advances in preparation and engineering of plant-derived extracellular vesicles for nutrition intervention

Abstract 2720: Enhancing Oral Delivery of Plant-Derived Vesicles

Optimization and Characterization of PEG Extraction Process for Tartary Buckwheat-Derived Nanoparticles

Engineering Poly(ethylene Glycol) Nanoparticles for Accelerated Blood Clearance Inhibition and Targeted Drug Delivery.

Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X

Quantitatively fine-tuning the physicochemical and biological properties of peptidic polymers through monodisperse PEGylation.

Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation

To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives

Engineering Strategies of Plant-Derived Exosome-Like Nanovesicles: Current Knowledge and Future Perspectives

Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions